News

Cardiovascular disease: key molecular pathway affecting atherosclerosis progression discovered

Gesamtverträge für bildgebende Verfahren bringen österreichweite Verbesserungen

Flinn: Wiener Startup sichert 2 Mio. Euro FFG-Förderung für KI-Entwicklung

Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico

KI-gestützte Auswertung von skoliose bedingten Indikationen an der Wirbelsäule - ImageBiopsy Lab bringt IB Lab SQUIRREL auf den EU Markt

Genetischer Marker für Multiple Sklerose erforscht

Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

Specific connective tissue cells drive development of colorectal cancer

Cancer among people experiencing homelessness: Research into current situation forms basis for prevention programme

Privatklinik Confraternität: Künstliche Intelligenz in der Koloskopie

‘Human inks’ to 3D printing human tissues: HU3DINKS project brings together expert companies for the development of human tissue-based inks.

New Managing Director at Vela Labs in Vienna

4C Accelerator to enable your MedTech startup! Application until August 4th, 2023.

Martin Schepelmann coordinates the "eRaDicate" EU-project to research innovative ligands for nuclear receptors to eradicate cancer relapse

Deutsch-österreichischer Medizinprodukteanbieter auf Erfolgskurs

Introducing OatSens SugarFree: The Cutting-Edge Solution for Precise Sugar Measurement in Oat Drink

BMSGPK: Rauch/Kocher: EU-Pharmapaket soll Medikamentenversorgung langfristig sicherstellen

Personalised risk profile developed for patients with liver disease

Wissenschaftler*innen der Med Uni Graz erforschen Lipoprotein-Lipase

Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan